Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HE.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.99EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HW.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HA.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GM.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GJ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JH.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.2.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FY.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FT.3.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.4.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JZ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HS.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.73EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HV.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.8.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.4.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDREWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.43.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.28EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KV.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.39EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JD.1.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used